Jun. 6 at 1:46 PM
$PMI three keys , Filing plan with NYSE to regain compliance, FDA designation change on the STAH from imminent death to Bridge to Transpant. Will significantly increase sales of the device, more money , regain compliance. Advance the ETAH to human implantation , there is no telling how high this goes.